STOCK TITAN

RXRX (NASDAQ: RXRX) restricted stock sale of 7,956 Class A shares filed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RXRX submitted a Form 144 reporting the proposed sale of 7,956 Class A shares tied to restricted stock vesting on 03/15/2026. The filing lists prior dispositions by Ben Taylor of 21,383 Class A shares on 12/29/2025 and 13,426 Class A shares on 02/18/2026. The broker listed is Fidelity Brokerage Services LLC.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies market of a planned restricted‑stock sale following vesting.

Form 144 records a proposed sale of 7,956 Class A shares by reason of Restricted Stock Vesting on 03/15/2026. The filing names Fidelity Brokerage Services LLC as broker/agent.

Reported prior dispositions by Ben Taylor (21,383 and 13,426 shares) appear as recent secondary sales; timing and cash‑flow treatment are limited to the stated dates and amounts.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RXRX's Form 144 report?

Form 144 reports a proposed sale of 7,956 Class A shares tied to restricted stock vesting on 03/15/2026. It also lists prior sales by Ben Taylor of 21,383 and 13,426 Class A shares on the stated dates.

Who is the broker handling the RXRX sale listed on Form 144?

The filing lists Fidelity Brokerage Services LLC as the broker/agent associated with the securities. The entry includes an address line and indicates the transaction type is a brokered disposition tied to the vesting event.

Were there recent RXRX insider or related-party sales disclosed?

Yes. The filing shows Ben Taylor sold 21,383 Class A shares on 12/29/2025 and 13,426 Class A shares on 02/18/2026. These amounts are reported in the "Securities Sold During The Past 3 Months" section.

What is the reason given for the 7,956 share sale in the RXRX Form 144?

The stated reason for the 7,956 Class A shares sale is Restricted Stock Vesting, with the issuer listed as the source and an effective date of 03/15/2026 for the vesting event.

Does the Form 144 state who receives proceeds from the RXRX sale?

The excerpt ties the 7,956 shares to Issuer compensation vesting, but it does not detail cash‑flow recipients or proceeds handling beyond listing the issuer and broker in the provided lines.
Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

View RXRX Stock Overview

RXRX Rankings

RXRX Latest News

RXRX Latest SEC Filings

RXRX Stock Data

1.81B
507.18M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SALT LAKE CITY